3EKRYAN G, LAMEIRE N, BARSOUM R, et al. The burden of kidney disease:improving global outcome[ J ]. Kidney Int, 2004, 66( 11 ) :1310 - 1314.
4BREZEZINSI A. Melatonin in humans [ J ]. N Engl J Med, 1997, 336(2) :186 - 195.
5VILJOEN M, STEYN M E, VAN RENSBURG B W, et al. Melatonin in chronic renal failure [ J]. Nephron, 1992, 60 (2) :138 - 142.
6LUDEMANN P, ZWERNEMANN S, LERCHL A. Clearance of melatonin and 6-sulfatoxy melatonin by hemodialysis in patients with end-stage renal disease [ J ]. J Pineal Res, 2001, 31(2) :222-227.
7RAIJ I, AZAR S, KEANE W. Mesangial immune injury, hypertension and progression glomerular damage in Dahl rats[ J]. Kidney Int, 1984, 26:137 - 145.
8SENER G, SEHIRLI A O, KEYER-UYSAL M, et al. The protective effect of melatonin on renal ischemia-reperfusion injury in the rat [ J ]. J Pineal Res, 2002, 32 ( 1 ) : 120 - 126.
9RODRIGUEZ C, MAYO J C, SSINZ R M, et al. Regulation of antioxidant enzymes:a significant role for melatonin [ J ]. J Pineal Res, 2004, 36 ( 1 ) : 1 - 9.
